Skip to main content

HeartBeam, Inc.

BEAT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001779372

No open-market purchases or sales by HeartBeam, Inc. insiders were filed in the last 90 days; 41 institutions reported holding it in 13F filings for Q2 2026, worth $6.08M in total; no superinvestor holds it.

Other share classesBEATW

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by HeartBeam, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for HeartBeam, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for HeartBeam, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Persen Kenneth HarryChief Technology Officer448,290Jul 24, 20261
Cruickshank TimCFO239,990Jul 24, 20264
Vajdic BranislavPresident3,970,784Jul 24, 20264
Ferrari Richard MDirector286,636Apr 24, 20263
Strome Mark EDirector3,650,000IndirectApr 16, 20264
Ortigas-Wedekind MargaDirector137,293Apr 16, 20263
Elfrink WillhemDirector538,667Apr 16, 20263
ENO Robert PaulPresident36,742Apr 16, 20263
Jaff Michael RDirector31,250IndirectApr 16, 20263
De Urioste GeorgeDirector0Mar 23, 20263
Nelson Kenneth Warwick IIIDirector144,388Mar 23, 20262
Brounstein Richard DChief Financial Officer112,108Feb 14, 20230
Hunt Jon PatrickChief Business Officer23,976IndirectJun 17, 20220
Baumel AlanChief Operating Officer–Jun 17, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 24, 2026 (view filing)Apr 168 daysFerrari Richard MDirectorPPurchase+57.5K$0.80+$46.0K+25.1%286.6K afterAmended
Apr 16, 2026 (view filing)Apr 16Same dayCruickshank TimCFOPPurchase+31.3K$0.80+$25.0K+76.3%72.2K after
Apr 16, 2026 (view filing)Apr 16Same dayElfrink WillhemDirectorPPurchase+187.5K$0.80+$150.0K+53.4%538.7K after
Apr 16, 2026 (view filing)Apr 16Same dayJaff Michael RDirectorPPurchase+31.3K$0.80+$25.0KNew position31.3K after
Apr 16, 2026 (view filing)Apr 16Same dayVajdic BranislavDirectorPPurchase+31.3K$0.80+$25.0K+3.6%909.9K after
Apr 16, 2026 (view filing)Apr 16Same dayENO Robert PaulPresidentPPurchase+12.5K$0.80+$10.0K+51.6%36.7K after
Apr 16, 2026 (view filing)Apr 16Same dayOrtigas-Wedekind MargaDirectorPPurchase+25.0K$0.80+$20.0K+22.3%137.3K after
Apr 16, 2026 (view filing)Apr 16Same dayStrome Mark EDirectorPPurchase+750.0K$0.80+$600.0K+25.9%3.65M after
Dec 22, 2025 (view filing)Dec 175 daysLateStrome Mark E10% OwnerSSale−250.0K$3.58−$895.0K−7.9%2.90M after
Dec 19, 2025 (view filing)Dec 17-182 daysDe Urioste GeorgeDirectorSSale−57.1K$3.19−$182.1K−100.0%0 after2 lots
Feb 21, 2025 (view filing)Feb 147 daysLateFerrari Richard MDirectorPPurchase+29.4K$1.70+$50.0K+19.6%179.1K after
Feb 21, 2025 (view filing)Feb 147 daysLateCruickshank TimCFOPPurchase+17.6K$1.70+$30.0KNew position17.6K after
Sep 11, 2024 (view filing)Sep 65 daysLateDe Urioste GeorgeDirectorSSale−1.67K$2.34−$3.92K−2.8%57.1K after
Sep 4, 2024 (view filing)Aug 305 daysDe Urioste GeorgeDirectorSSale−5.50K$2.31−$12.7K−8.6%58.8K after
Aug 29, 2024 (view filing)Aug 272 daysDe Urioste GeorgeDirectorSSale−2.19K$2.26−$4.96K−3.3%64.3K after
Aug 27, 2024 (view filing)Aug 23-264 daysDe Urioste GeorgeDirectorSSale−2.80K$2.31−$6.46K−4.0%66.5K after2 lots
Oct 3, 2023 (view filing)Sep 294 daysDe Urioste GeorgeDirectorSSale−5.50K$2.06−$11.3K−13.2%36.1K after
Sep 29, 2023 (view filing)Sep 27-282 daysDe Urioste GeorgeDirectorSSale−9.83K$2.05−$20.2K−19.1%41.6K after2 lots
Sep 27, 2023 (view filing)Sep 22-265 daysLateDe Urioste GeorgeDirectorSSale−7.39K$2.13−$15.7K−12.6%51.5K after2 lots
Sep 22, 2023 (view filing)Sep 20-212 daysDe Urioste GeorgeDirectorSSale−983$2.45−$2.41K−1.6%58.9K after2 lots
Sep 19, 2023 (view filing)Sep 15-184 daysDe Urioste GeorgeDirectorSSale−9.27K$2.45−$22.7K−13.4%59.8K after2 lots
Sep 15, 2023 (view filing)Sep 13-142 daysDe Urioste GeorgeDirectorSSale−10.0K$2.05−$20.5K−12.6%69.1K after3 lots
Apr 4, 2022 (view filing)Mar 305 daysLateBrounstein Richard DChief Financial OfficerPPurchase+10.0K$0.00$0–10.0K afterDerivative
Mar 31, 2022 (view filing)Mar 292 daysVajdic BranislavChief Executive OfficerPPurchase+10.0K$0.00$0–35.0K afterDerivative
Jan 6, 2022 (view filing)Dec 30, 20217 daysVajdic BranislavChief Executive OfficerPPurchase+25.0K$0.00$0–25.0K afterAmendedDerivative
Dec 23, 2021 (view filing)Dec 212 daysBrounstein Richard DChief Financial OfficerPPurchase+5.00K$3.37+$16.9K+5.2%102.1K after
Nov 15, 2021 (view filing)Nov 114 daysBrounstein Richard DCHIEF FINANCIAL OFFICERPPurchase+5.00K$5.99+$29.9K+5.4%97.1K after
Nov 15, 2021 (view filing)Nov 114 daysOrtigas-Wedekind MargaDirectorPPurchase+9.00K$5.99+$53.9K+115.0%16.8K after